WhatsApp Skip to main content

Dr. Harsh J Shah

Rectal Cancer Trials: Which Ones Changed Treatment?

Last updated: 27-Oct-2026

Dr Harsh Shah, GI surgeon, Ahmedabad

Dr Harsh Shah
MS, MCh (Surgical Gastroenterology), DrNB (Surgical Gastroenterology)
Registered with Gujarat Medical Council, Reg. No. G-38738
Gastro & Cancer Surgeon
Apollo Hospital, Bhat, Gandhinagar · Gota OPD, Ahmedabad · 18 years of experience
★★★★★ Google: 4.89 from 216 reviews (Gota clinic) · 4.94 from 18 reviews (Apollo, Bhat)

In short

A small set of large trials shaped today’s rectal cancer care. They cover radiation, chemotherapy, the operation, and saving the rectum.

Most trials ask one narrow question, such as whether a step can be shortened or skipped. Each answer helps a defined group of patients.

Your own scan, the level of the growth and your health decide which result applies to you.

If you already have the diagnosis, the plan of care is on the middle rectal cancer surgery page. This post explains the trials behind that plan, in plain words.

Why do rectal cancer trials matter?

A trial compares two ways of treating similar patients. It shows which way is better, or whether a gentler way is just as good.

  • A new step is only added when a trial shows it helps.
  • An old step is only dropped when a trial shows nothing is lost.
  • Results hold for patients like those studied. A trial of low cancers may not suit a high one.
  • Your team should tell you which trials back your plan.

For the usual plan at each stage, see our post on what the main guidelines agree on. Guidelines are built from the trials below.

Which trials shaped treatment before surgery?

These trials moved radiation and chemotherapy to before the operation. The aim is to shrink the growth and lower the chance of it returning.

Trials on treatment given before rectal cancer surgery
TrialQuestion askedWhat it showed
Dutch TME trialDoes short radiation before careful surgery help?It lowered the chance of the cancer growing back in the pelvis
German Sauer trialRadiation with chemotherapy before or after surgery?Before was better for pelvic control and was easier to tolerate
Polish and Stockholm III trialsShort radiation or long radiation with chemotherapy?Survival was similar, so the short course is a practical choice
RAPIDOShort radiation, then chemotherapy, then surgery?Fewer patients had cancer return anywhere in the body, but local regrowth was a little higher
PRODIGE 23Strong chemotherapy before chemoradiation?Cancer stayed away longer, with more side effects from the drugs
PROSPECTCan chemotherapy alone replace radiation for some patients?For chosen patients with a safe margin, results were the same without radiation

Giving all treatment first is now common for advanced growths. Radiation and chemotherapy are explained further on the page about rectal cancer organ preservation.

Which trials shaped the operation itself?

These trials asked how the rectum should be removed, and which method keeps the cancer result safe.

Trials on the rectal cancer operation
TrialQuestion askedWhat it showed
COLOR IIKeyhole or open surgery for rectal cancer?Cancer results were similar, with quicker recovery after keyhole
ACOSOG Z6051 and ALaCaRTIs the removed specimen as good with keyhole surgery?Early reports raised doubts about specimen quality. Later survival was similar
ROLARRRobotic or keyhole surgery?The need to switch to open surgery was not clearly different
JCOG0212Should side-wall pelvic nodes be removed in low cancers?It was not proven safe to skip them. Removal lowered side-wall regrowth but added urinary and sexual side effects

These results explain why a careful, complete mesorectal dissection matters more than the tool. Choices for low growths are covered on the page for lower rectal cancer.

Which trials support saving the rectum?

Some patients see the growth vanish after treatment. These studies ask if surgery can then be avoided, and what the safe conditions are.

  • GRECCAR 2: for small low cancers that shrank well, local removal was not better than full surgery. Some patients needed a second operation.
  • OPRA: giving chemotherapy after radiation, not before it, kept more patients from needing surgery.
  • Habr-Gama series and the international watch-and-wait registry: many patients stayed well under close watching. A part had regrowth, mostly caught early.
  • Dostarlimab study: in a small group with a mismatch-repair deficient tumour, immunotherapy alone cleared the growth in every patient. The group is small, so follow-up continues.

Watchful waiting is safe only with close checks. You need scans, scope checks and a surgeon who can act fast. It is not the right choice for everyone.

What about cancer that has spread?

For spread to the liver or lungs, most evidence comes from trials of bowel cancer as a whole. It applies to rectal cancer too.

  • Drug choice depends on gene tests of the tumour, such as KRAS, BRAF, HER2 and mismatch repair.
  • Tumours with mismatch-repair loss respond well to immunotherapy given first, as shown in the KEYNOTE-177 trial.
  • BEACON and other trials support targeted drugs for tumours with a BRAF change.
  • A spread that can be removed is often planned with surgery on the rectum and the other organ together.

What can a trial not tell you?

A trial reports an average. It cannot say how you in particular will do, and it cannot see your scan.

  • Patients in trials are often younger and fitter than patients in daily practice.
  • Some trials were done in countries with different drug access and scan quality.
  • New trials appear each year, so a result may be updated or refined.
  • A headline does not tell you the side effects or the long-term bowel function.

That is why every plan is made after a pelvic MRI, a review of your biopsy and a team discussion. If you are unsure, bring your reports for a second opinion.

Questions to ask your doctor

  • Which trials back my treatment plan?
  • Is my stage one that was studied in those trials?
  • Can my treatment before surgery be shortened or made gentler?
  • Am I a candidate for watchful waiting if the growth disappears?
  • Has my tumour been tested for mismatch repair and other genes?

Frequently asked questions

Which trials changed rectal cancer treatment the most?

The Dutch TME trial, the German Sauer trial, RAPIDO, PRODIGE 23, PROSPECT and OPRA changed how radiation and chemotherapy are used. COLOR II and JCOG0212 shaped surgery.

Can I skip radiation for rectal cancer?

Some patients can. The PROSPECT trial showed that chosen patients with a safe margin did as well with chemotherapy first and no radiation. Your scan decides if you qualify.

Is watch-and-wait proven?

It is supported by cohort studies and by OPRA, but it is not right for everyone. It needs close checks and a team ready to operate if the growth returns.

Why do trial results differ from my own plan?

A trial gives an average for a defined group. Your level in the rectum, your scan, your age and your health can change the right plan for you.

Does immunotherapy work in rectal cancer?

It works very well in tumours with mismatch-repair loss, which are a small group. A gene test of the biopsy tells you if you are in it.

Should I read the trials myself?

You can, but a trial cannot see your scan. Use the results to ask better questions, and bring your reports to a surgeon.

Where Dr Harsh Shah sees patients and operates

Shah’s Gastro, Cancer & Robotic Surgery Centre, Gota, Ahmedabad

Consultation, review of endoscopy, biopsy and scan reports, second opinions and follow-up.

+91-63555-64601 · Directions to the Gota clinic

Apollo Hospital, Bhat, Gandhinagar

Apollo Hospital International Limited, GIDC Bhat Industrial Estate, Bhat, Gandhinagar. Endoscopy and biopsy, CT scans, surgery for stomach and duodenal disorders, and inpatient care.

WhatsApp +91-63555-64601 · Directions to Apollo, Bhat

Read about a trial and wonder if it applies to you? A trial result is an average for a group of patients. Send your reports on WhatsApp, or book a visit. Dr Harsh Shah will explain which results fit your rectal cancer. Call +91-63555-64601 Send your reports on WhatsApp

Rate this post

Get health updates from Dr Harsh Shah on WhatsApp

Swasth Parivar: every week, practical advice on recovery, diet and warning signs. No advertising. Stop any time.

Your number is used for these updates and for the clinic to reach you. It is never sold or passed on. To stop, reply STOP on WhatsApp.

Dr. Harsh J Shah
Dr Harsh Shah - Surgical Gastroenterologist and GI Robotic Surgeon, Ahmedabad
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.